In Dec. 2024, a significant conference in the vitamin industry was held, with domestic mainstream manufacturers expressing a willingness to support prices, but downstream terminals showed a strong wait-and-see attitude, purchasing on demand, and the market's buying and selling atmosphere was average, with actual transactions and exports accounting for a large proportion. The prices of different vitamins varied. The price of folic acid continued to rise and the decline of vitamin K3 temporarily slowed down.
The National Health Commission (NHC) issued an announcement to expand the use scope of the food nutrient fortifier "(6S)-5-Methyltetrahydrofolate, Glucosamine Salt".
Eastroc Beverage is planning to list in Hong Kong in 2025, aiming to raise up to USD1 billion in funds.
- Project progress of many companies
- Siyikang's artemisinin and coenzyme Q10 reconstruction and expansion project;
- Kexing Pharmaceutical's 15,800 t/a flavour and fragrance production line expansion project;
- Richen Bioengineering's vitamin granules, nutrient microcapsules and other products project;
- Nugene Pharma's vitamin PQQ and bio-enzyme TPL technical improvement project;
The USD/RMB exchange rate in this Report is USD1.00=CNY7.1865 on 2 Dec., 2024, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
